Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine

5 May 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Complement system in diseases
Share to Renal Diseases and Glomerulopathies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33964312
DOI: 10.1016/j.kint.2021.04.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Minimal change disease relapse following SARS-CoV-2 mRNA vaccinePMID 33964312Read ↗

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19Semantic proximity Read ↗

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansSemantic proximity Read ↗

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical ConditionsSemantic proximity Read ↗

Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationSemantic proximity Read ↗

SARS-CoV-2 evolution and vaccines: cause for concern?Semantic proximity Read ↗

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal diseaseSemantic proximity Read ↗

Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccinationSemantic proximity Read ↗

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerSemantic proximity Read ↗

mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune DisordersSemantic proximity Read ↗

Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccineSemantic proximity Read ↗

mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2Semantic proximity Read ↗

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial ProtocolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.